R&D Investor Webinar

Home » Uncategorized » R&D Investor Webinar

Thank you to those that joined us for our first R&D Webinar. We had a great response and an engaged audience. For those that missed it, you can view the full recording via the link below. Topics covered on the day included:

  • The strong science behind HXP124 and how R&D is illuminating the potential of HXP124 as a new and attractive treatment for onychomycosis;
  • The unique properties of HXP124 and why it is potentially an ideal solution for a large and poorly served market;
  • An introduction to our Scientific Advisory Board and their support for HXP124’s development as a new therapy for onychomycosis.

View R&D Webinar recording here R&D Recording